Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply

Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply Contains NACI's independent advice and recommendations, which are based upon the best current available scientific knowledge. The objective is to provide guidance for the equitable, ethical, and efficient allocation of authorized COVID-19 vaccines in the context of staggered arrival of vaccine supply. 2021-06-30 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetyEthicsequityfeasibilitycovid-19vaccinesvaccine rolloutCIConfidence intervalEEFAand acceptabilityHCWHealth care workerLTCFLong-term care facilitymRNAMessenger ribonucleic acidNACINational Advisory Committee on ImmunizationPCRPolymerase chain reactionPHACPublic Health Agency of CanadaVEVaccine effectivenessBritish Columbia (BC) COVID-19 vaccine extended dose intervals for early vaccine rollout and population protection in Canada: NACI recommendationsHTML https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/extended-dose-intervals-covid-19-vaccines-early-rollout-population-protection.html COVID-19 vaccine extended dose intervals for early vaccine rollout and population protection in Canada: NACI recommendationsHTML https://www.canada.ca/fr/sante-publique/services/immunisation/comite-consultatif-national-immunisation-ccni/allongement-intervalles-doses-vaccins-covid-19-campagnes-precoces-protection-population.html

Contains NACI's independent advice and recommendations, which are based upon the best current available scientific knowledge. The objective is to provide guidance for the equitable, ethical, and efficient allocation of authorized COVID-19 vaccines in the context of staggered arrival of vaccine supply.

Data and Resources

Similar records